Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

HPV Ends Here: Increasing Uptake of the HPV Vaccine

University of California, Davis · with National Cancer Institute (NCI) · NCT06831929

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 10–12 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
2232
US sites recruiting
1
Study start
February 28, 2025
Record last updated
August 11, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

Being studied: Intervention Arm

Conditions: HPV Vaccine

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine

Exclusion Criteria

  • Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.

Recruiting US locations

  • University of California Davis Health

    Sacramento, CA 95817

    Site contact: Julie HT Dang, PhD · jtdang@ucdavis.edu

Study contacts (from the official record)

  • Julie Dang, PhD, MPH · 9167345222 · jtdang@health.ucdavis.edu
All vaccine studies in California →
HPV Ends Here: Increasing Uptake of the HPV Vaccine (NCT06831929) | Bored Studies